Navigation Links
Reportlinker Adds Innovative Drug Discovery in Emerging Markets
Date:1/11/2011

NEW YORK, Jan. 11, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Innovative Drug Discovery in Emerging Markets

http://www.reportlinker.com/p0359990/Innovative-Drug-Discovery-in-Emerging-Markets.html

Introduction Emerging markets have represented important growth opportunities for the global pharmaceutical industry, but it has been unclear the extent to which this has been accompanied by growth in domestic innovation within these countries. This report examines the most prominent domestic innovators, assessing key research strategies, front-running candidates, scientific strengths, and patent portfolios.

Features and benefits * Assess the extent of innovative drug discovery occurring in each if the emerging markets and compare the output of pharmaceutical patent applications.

* Understand the factors that have encouraged or hindered innovative research and gain insight into the wider environment faced by innovators.

* Identify the most prominent innovative companies in each country and understand the role of innovation within their broader business strategies.

* Identify each company's therapeutic priorities, research strategies, scientific strengths, key pipeline projects, and intellectual property.

* Gain insight into the most promising innovative preclinical and clinical candidates and the science on which they are based.

Highlights Of the large number of companies assessed for evidence of innovative drug discovery, only a small proportion met our criteria for inclusion. In total 47 profiles are provided. A common feature is that these companies have a source of revenue aside from innovative drugs. Pure research-based innovators funded solely by venture capital are rare.

Drugs derived from botanical sources feature heavily in the pipelines of innovative companies from several of the emerging markets. These drugs range from multi-component extracts to synthetic compounds based on natural product leads. Some companies are applying a high-technology approach to understanding the mechanism of action of botanical drugs.

While China in particular can boast the successful innovation of novel drugs (gene therapies) ahead of companies in the West, it is notable that regulatory approvals for successful drugs have been limited to the country of origin. A novel drug of global importance is yet to appear from the emerging markets, but the potential in niche areas is high.

Your key questions answered * Have countries with large growth in their pharmaceutical markets also undergone growth in the pursuit of innovative drugs?

* Which countries have fostered an environment conducive to innovative drug discovery, and how have the domestic pharmaceutical industries evolved?

* Which are the most prominent domestic innovators, what is their background, and what therapeutic advances are they aiming to achieve?

* What pipeline drugs do domestic companies have, what is their current status, and what will they be competing with if they reach the market?

* What are the chemical structures of lead entities, what international patents have been filed, and which companies are seeking collaborations?

To order this report:: Innovative Drug Discovery in Emerging Markets

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!Contact:Nicolas BombourgReportlinkerEmail: nbo@reportlinker.comUS: (805) 652-2626Intl: +1 805-652-2626
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Reportlinker Adds US Disposable Medical Supplies Market Report
2. Reportlinker Adds Gilead Sciences Inc.: PharmaVitae Profile
3. Reportlinker Adds Drug Delivery Partnering Agreements in Pharma and Biotech
4. Reportlinker Adds Global Medical Devices Industry Outlook to 2010: Marketing And Sales Strategies And The Impact of Recession And Recovery
5. Reportlinker Adds Reinventing Pharmaceutical Sales Forces
6. Reportlinker Adds Computer Assisted Coding Of Medical Information Market Shares, Strategies, and Forecasts 2008 to 2014
7. Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery
8. Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015
9. Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities
10. Reportlinker Adds Global Top 10 Chemical Companies -- Industry, Financial and SWOT Analysis
11. Reportlinker Adds Pharma 101: An Overview of the Life Sciences Industry (Analyst Insight)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... The key factors driving the growth of dialysis ... growth and increasing healthcare expenditure. Some of the noteworthy trends ... ESRD patients, rising demand for home PD treatment and huge ... market is hindered by high treatment costs and stringent regulations. ... Complete ...
(Date:3/23/2017)... INDIANAPOLIS , March 23, 2017  Eli ... the William Sansum Diabetes Center have established a research ... by diabetes through enhanced research, education and care. ... disease bears a disproportionate weight on Latino families in ... David Kerr , M.D., FRCPE, director of Innovation and ...
(Date:3/23/2017)... March 23, 2017   BioSpace , the leading ... partnered with Indiana Biosciences Research Institute and ... and educational institutions to bring the state,s life sciences ... Hotbed map, an artistic representation of the region,s booming ... to Vice President Mike Pence , a long-time ...
Breaking Medicine Technology:
(Date:3/23/2017)... York, NY (PRWEB) , ... March 23, 2017 , ... 82% of adults are unaware ... 3 kids do not brush their teeth the minimum two times a day that dentists ... with students missing 51 million hours of school and adults missing 164 million hours of ...
(Date:3/23/2017)... ... March 23, 2017 , ... The StayWell Company announced today ... accreditation covers StayWell’s asthma, coronary artery disease, congestive heart failure, chronic obstructive pulmonary ... have excellent programs for the delivery and improvement of disease management and that ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... and businesses of the greater Fort Collins area, has unveiled a collaboration with ... community involvement program. Donations to this worthy cause may now be made at ...
(Date:3/23/2017)... ... , ... ?This conference will prominently feature 150+ Hospital and Health System Executive Speakers including: , ... , 43rd President of the United States of America: George W. Bush , ... Out of the Ring: Sugar Ray Leonard , JD, Chairperson, McGuireWoods LLP: Amber ...
(Date:3/23/2017)... ... March 23, 2017 , ... Natural ... all aspects of people’s health and nutrition, announced its product Leyzene is now ... Natural Subsistence develops nutritional supplements that help people improve all aspects of their ...
Breaking Medicine News(10 mins):